398 related articles for article (PubMed ID: 19925945)
1. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE
Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945
[TBL] [Abstract][Full Text] [Related]
2. Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies.
Wu X; Franka R; Henderson H; Rupprecht CE
Vaccine; 2011 Jun; 29(25):4195-201. PubMed ID: 21514343
[TBL] [Abstract][Full Text] [Related]
3. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
4. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
[TBL] [Abstract][Full Text] [Related]
6. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA
Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019
[TBL] [Abstract][Full Text] [Related]
8. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
Lodmell DL; Esposito JJ; Ewalt LC
Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of live attenuated and inactivated rabies viruses in prophylactic and post exposure vaccination against the street virus strain.
Huang F; Ahmad W; Duan M; Liu Z; Guan Z; Zhang M; Qiao B; Li Y; Song Y; Song Y; Chen Y; Amjad Ali M
Acta Virol; 2015 Jun; 59(2):117-24. PubMed ID: 26104328
[TBL] [Abstract][Full Text] [Related]
10. Efficient post-exposure prophylaxis against rabies by applying a four-dose DNA vaccine intranasally.
Tesoro Cruz E; Feria Romero IA; López Mendoza JG; Orozco Suárez S; Hernández González R; Favela FB; Pérez Torres A; José Alvaro Aguilar Setién
Vaccine; 2008 Dec; 26(52):6936-44. PubMed ID: 18940223
[TBL] [Abstract][Full Text] [Related]
11. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
[TBL] [Abstract][Full Text] [Related]
12. [Oral vaccination in the control of feral rabies].
Biocca E; Bellani L
Parassitologia; 1988; 30(1):3-12. PubMed ID: 3268770
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity study of abbreviated rabies preexposure vaccination schedules.
Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P
J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473
[TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of P gene-deficient rabies virus.
Shoji Y; Inoue S; Nakamichi K; Kurane I; Sakai T; Morimoto K
Virology; 2004 Jan; 318(1):295-305. PubMed ID: 14972555
[TBL] [Abstract][Full Text] [Related]
15. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
Landry P; Lazzaro M; Darioli R
Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997
[TBL] [Abstract][Full Text] [Related]
16. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
Rupprecht CE; Briggs D; Brown CM; Franka R; Katz SL; Kerr HD; Lett SM; Levis R; Meltzer MI; Schaffner W; Cieslak PR;
MMWR Recomm Rep; 2010 Mar; 59(RR-2):1-9. PubMed ID: 20300058
[TBL] [Abstract][Full Text] [Related]
17. Studies on an inactivated vaccine against rabies virus in domestic animals.
Monaco F; Franchi PM; Lelli R
Dev Biol (Basel); 2006; 125():233-9. PubMed ID: 16878481
[TBL] [Abstract][Full Text] [Related]
18. Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity.
Monath TP; Lee CK; Julander JG; Brown A; Beasley DW; Watts DM; Hayman E; Guertin P; Makowiecki J; Crowell J; Levesque P; Bowick GC; Morin M; Fowler E; Trent DW
Vaccine; 2010 May; 28(22):3827-40. PubMed ID: 20347059
[TBL] [Abstract][Full Text] [Related]
19. Reduction in the dosage schedule of BPL-inactivated neural tissue vaccine for rabies prophylaxis in man.
Tripathi KK; Madhusudana SN; Sahu A
Indian J Med Res; 1990 Sep; 91():334-9. PubMed ID: 2269504
[TBL] [Abstract][Full Text] [Related]
20. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
